A Pennsylvania physician can’t sue a federal investigator and prosecutor who allegedly unjustifiably accused him of violating the Controlled Substances Act, a federal court said.
Elias Karkalas didn’t have a private right of action against Drug Enforcement Agency investigator Kimberly Brill or attorney Linda Marks for malicious prosecution under the Fourth Amendment, the U.S. District Court for the Eastern District of Pennsylvania said July 31.
Karkalas worked for Rx Limited, an online pharmacy company. He approved requests for prescriptions for Fioricet, a drug that contains butalbital, a Schedule III controlled substance.
Brill believed Fioricet is a controlled substance and convinced ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.